BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29804481)

  • 1. Clinical reappraisal of the influence of drug-transporter polymorphisms in epilepsy.
    Orlandi A; Paolino MC; Striano P; Parisi P
    Expert Opin Drug Metab Toxicol; 2018 May; 14(5):505-512. PubMed ID: 29804481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
    Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
    Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
    Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
    Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.
    Soranzo N; Kelly L; Martinian L; Burley MW; Thom M; Sali A; Kroetz DL; Goldstein DB; Sisodiya SM
    Epilepsia; 2007 Apr; 48(4):674-83. PubMed ID: 17437410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ABC transporters and drug resistance in epilepsy: biological plausibility, pharmacogenetics and precision medicine].
    Riquelme-Alcázar J; González-Vargas R; Moya PR
    Rev Neurol; 2020 Jan; 70(1):23-32. PubMed ID: 31845753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical impact of pharmacogenetics on the treatment of epilepsy.
    Löscher W; Klotz U; Zimprich F; Schmidt D
    Epilepsia; 2009 Jan; 50(1):1-23. PubMed ID: 18627414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RLIP76 in AED drug resistance.
    Janigro D; Awasthi S; Awasthi YC; Sharma R; Yadav S; Singhal SS; Hallene K
    Epilepsia; 2007 Jun; 48(6):1218-9; author reply 1219-20. PubMed ID: 17553125
    [No Abstract]   [Full Text] [Related]  

  • 8. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
    Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K
    Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
    Taur SR; Kulkarni NB; Gandhe PP; Thelma BK; Ravat SH; Gogtay NJ; Thatte UM
    J Postgrad Med; 2014; 60(3):265-9. PubMed ID: 25121365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug transporters in the epileptic brain.
    Löscher W
    Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of common variation in drug transporter genes in refractory epilepsy.
    Soranzo N; Goldstein DB; Sisodiya SM
    Expert Opin Pharmacother; 2005 Jul; 6(8):1305-12. PubMed ID: 16013981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy.
    Xiong J; Mao DA; Liu LQ
    Biomed Res Int; 2015; 2015():194541. PubMed ID: 26491660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis.
    Haerian BS; Roslan H; Raymond AA; Tan CT; Lim KS; Zulkifli SZ; Mohamed EH; Tan HJ; Mohamed Z
    Seizure; 2010 Jul; 19(6):339-46. PubMed ID: 20605481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms Affecting the Response to Novel Antiepileptic Drugs.
    Urzì Brancati V; Pinto Vraca T; Minutoli L; Pallio G
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis.
    Chouchi M; Kaabachi W; Klaa H; Tizaoui K; Turki IB; Hila L
    BMC Neurol; 2017 Feb; 17(1):32. PubMed ID: 28202008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Personalized medicine for epilepsy based on the pharmacogenomic testing].
    Yoshida S; Sugawara T; Nishio T; Kaneko S
    Brain Nerve; 2011 Apr; 63(4):295-9. PubMed ID: 21441631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between polymorphism in ABCC2 gene and response to antiepileptic drug treatment in Croatian patients with epilepsy.
    Sporis D; Bozina N; Basić S; Lovrić M; Babić T; Susak I; Marković I
    Coll Antropol; 2013 Mar; 37(1):41-5. PubMed ID: 23697249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance in epilepsy: a pharmacogenomic update.
    Tate SK; Sisodiya SM
    Expert Opin Pharmacother; 2007 Jul; 8(10):1441-9. PubMed ID: 17661727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasticity of antiepileptic drug targets.
    Beck H
    Epilepsia; 2007; 48 Suppl 1():14-8. PubMed ID: 17316408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches.
    Leandro K; Bicker J; Alves G; Falcão A; Fortuna A
    Pharmacol Res; 2019 Jun; 144():357-376. PubMed ID: 31051235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.